» Articles » PMID: 31191754

Circulating MicroRNA-499 As a Diagnostic Biomarker for Acute Myocardial Infarction: A Meta-analysis

Overview
Journal Dis Markers
Publisher Wiley
Specialty Biochemistry
Date 2019 Jun 14
PMID 31191754
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent studies have shown that circulating microRNA-499 could be a powerful biomarker of acute myocardial infarction (AMI). Interest in circulating microRNA-499 for detecting AMI is increasing rapidly. To evaluate the diagnosis of circulating microRNA-499 for AMI, this study was performed.

Methods: We searched PubMed, Embase, and the Cochrane Library for studies published up to December 31, 2018, as well as the reference lists of relevant studies. Studies were included if they assessed the accuracy of blood circulating microRNA-499 or cardiac troponin T (cTnT) for AMI and provided sufficient data to construct a 2 × 2 contingency table. Extracted data were analysed for sensitivity, specificity, diagnostic odds ratio (DOR), and summary receiver operator curve (SROC) analyses. Prespecified subgroup analysis and metaregression were also performed.

Results: Fourteen studies including 3816 participants were included in this meta-analysis. The overall pooled sensitivity and specificity were 0.84 (95% CI: 0.64-0.94) and 0.97 (95% CI: 0.90-0.99), respectively. The area under the SROC curve (AUC) was 0.98 (95% CI: 0.96-0.99). The studies had substantial heterogeneity ( = 98.74%). Seven studies also used cTnT as a marker for the diagnosis of AMI. The overall pooled sensitivity and specificity of cTnT were 0.95 (95% CI: 0.87-0.98) and 0.96 (95% CI: 0.85-0.99), respectively. The area under the SROC curve (AUC) was 0.99 (95% CI: 0.97-0.99). The DOR of circulating miR-499 and cTnT were 188 (95% CI: 19-1815) and 420 (95% CI: 86-2038), respectively. Metaregression analysis suggested that specimen and healthy controls were the main sources of heterogeneity. No publication bias was suggested by Deeks' regression test of asymmetrical funnel plot ( = 0.85; value = 0.41).

Conclusion: The results showed that circulating microRNA-499 is a reliable biomarker for diagnosing AMI patients.

Citing Articles

Elevated miRNA-499 Levels in Early Phase of Non-ST Elevation Acute Coronary Syndromes Predict Increased Long-Term Risk of Major Adverse Cardiac Events.

Miskowiec D, Szymczyk E, Wejner-Mik P, Michalski B, Lipiec P, Simiera M J Clin Med. 2025; 13(24.

PMID: 39768724 PMC: 11727993. DOI: 10.3390/jcm13247803.


Circulating miRNA-21 as a diagnostic biomarker for acute coronary syndrome: a systematic review and meta-analysis of diagnostic test accuracy study.

He J, Li S, Wu X, Chen X, Yan D, Wang X Cardiovasc Diagn Ther. 2024; 14(3):328-339.

PMID: 38975002 PMC: 11223935. DOI: 10.21037/cdt-23-385.


Cardiac microRNAs: diagnostic and therapeutic potential.

Kablak-Ziembicka A, Badacz R, Okarski M, Wawak M, Przewlocki T, Podolec J Arch Med Sci. 2023; 19(5):1360-1381.

PMID: 37732050 PMC: 10507763. DOI: 10.5114/aoms/169775.


Identification of microRNAs as diagnostic biomarkers for atrial fibrillation: a systematic review and meta-analysis.

Rizal A, Waranugraha Y, Wikananda A, Yuniadi Y Front Cardiovasc Med. 2023; 10:1128708.

PMID: 37187791 PMC: 10181881. DOI: 10.3389/fcvm.2023.1128708.


Identification through machine learning of potential immune- related gene biomarkers associated with immune cell infiltration in myocardial infarction.

Dong H, Yan S, Li G, Huang Z, Li D, Tang Y BMC Cardiovasc Disord. 2023; 23(1):163.

PMID: 36978012 PMC: 10052851. DOI: 10.1186/s12872-023-03196-w.


References
1.
French J, White H . Clinical implications of the new definition of myocardial infarction. Heart. 2003; 90(1):99-106. PMC: 1768007. DOI: 10.1136/heart.90.1.99. View

2.
Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

3.
Deeks J, Macaskill P, Irwig L . The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005; 58(9):882-93. DOI: 10.1016/j.jclinepi.2005.01.016. View

4.
Kloosterman W, Plasterk R . The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006; 11(4):441-50. DOI: 10.1016/j.devcel.2006.09.009. View

5.
Wang G, Zhu J, Zhang J, Li Q, Li Y, He J . Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010; 31(6):659-66. DOI: 10.1093/eurheartj/ehq013. View